These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2431360)

  • 1. Binding of omega-conotoxin to receptor sites associated with the voltage-sensitive calcium channel.
    Abe T; Koyano K; Saisu H; Nishiuchi Y; Sakakibara S
    Neurosci Lett; 1986 Nov; 71(2):203-8. PubMed ID: 2431360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for distinct sites coupled to high affinity omega-conotoxin receptors in rat brain synaptic plasma membrane vesicles.
    Feigenbaum P; Garcia ML; Kaczorowski GJ
    Biochem Biophys Res Commun; 1988 Jul; 154(1):298-305. PubMed ID: 2840068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the receptor for omega-conotoxin in brain. Probable components of the calcium channel.
    Abe T; Saisu H
    J Biol Chem; 1987 Jul; 262(20):9877-82. PubMed ID: 2439513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the omega-conotoxin-binding molecule in rat brain synaptosomes and cultured neurons.
    Marqueze B; Martin-Moutot N; Levêque C; Couraud F
    Mol Pharmacol; 1988 Aug; 34(2):87-90. PubMed ID: 2457794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization.
    Wagner JA; Snowman AM; Biswas A; Olivera BM; Snyder SH
    J Neurosci; 1988 Sep; 8(9):3354-9. PubMed ID: 2845019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of specific 125I-omega-conotoxin GVIA binding and 125I-omega-conotoxin GVIA labeling using bifunctional crosslinkers in crude membranes from chick whole brain.
    Ichida S; Wada T; Akimoto T; Kasamatsu Y; Tahara M; Hasimoto K
    Biochim Biophys Acta; 1995 Jan; 1233(1):57-67. PubMed ID: 7833350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of structure and interaction of the receptor for omega-conotoxin, a polypeptide active on Ca2+ channels.
    Barhanin J; Schmid A; Lazdunski M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1051-62. PubMed ID: 2449205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types.
    Cruz LJ; Johnson DS; Olivera BM
    Biochemistry; 1987 Feb; 26(3):820-4. PubMed ID: 2436655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal calcium channel inhibitors. Synthesis of omega-conotoxin GVIA and effects on 45Ca uptake by synaptosomes.
    Rivier J; Galyean R; Gray WR; Azimi-Zonooz A; McIntosh JM; Cruz LJ; Olivera BM
    J Biol Chem; 1987 Jan; 262(3):1194-8. PubMed ID: 2433275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.
    Ballesta JJ; Palmero M; Hidalgo MJ; Gutierrez LM; Reig JA; Viniegra S; Garcia AG
    J Neurochem; 1989 Oct; 53(4):1050-6. PubMed ID: 2549193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different localization of receptors for omega-conotoxin and nitrendipine in rat brain.
    Takemura M; Fukui H; Wada H
    Biochem Biophys Res Commun; 1987 Dec; 149(3):982-8. PubMed ID: 2447889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA.
    Reynolds IJ; Wagner JA; Snyder SH; Thayer SA; Olivera BM; Miller RJ
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8804-7. PubMed ID: 2430302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the omega-conotoxin receptor in rat brain. An autoradiographic mapping.
    Takemura M; Kiyama H; Fukui H; Tohyama M; Wada H
    Neuroscience; 1989; 32(2):405-16. PubMed ID: 2555740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom.
    Olivera BM; Cruz LJ; de Santos V; LeCheminant GW; Griffin D; Zeikus R; McIntosh JM; Galyean R; Varga J; Gray WR
    Biochemistry; 1987 Apr; 26(8):2086-90. PubMed ID: 2441741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcium channel antagonist, omega-conotoxin, and electric organ nerve terminals: binding and inhibition of transmitter release and calcium influx.
    Ahmad SN; Miljanich GP
    Brain Res; 1988 Jun; 453(1-2):247-56. PubMed ID: 3401762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes.
    Knaus HG; Striessnig J; Koza A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):583-6. PubMed ID: 2830547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of presynaptic calcium channels revealed by species differences in the sensitivity of synaptosomal 45Ca entry to omega-conotoxin.
    Suszkiw JB; Murawsky MM; Fortner RC
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1283-6. PubMed ID: 2440429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social isolation increases the density of [125I]omega-conotoxin GVIA binding sites in the rat frontal cortex and caudate nucleus.
    Czyrak A; Dooley DJ; Jones GH; Robbins TW
    Brain Res; 1992 Jun; 583(1-2):189-93. PubMed ID: 1324093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the voltage-dependent Ca2+ channels present in synaptosomes from rat and chicken central nervous system.
    Alvarez Maubecin V; Sanchez VN; Rosato Siri MD; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Neurochem; 1995 Jun; 64(6):2544-51. PubMed ID: 7760034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of N-type Ca2+ channel binding sites in rabbit brain following central administration of omega-conotoxin GVIA.
    Whorlow SL; Loiacono RE; Angus JA; Wright CE
    Eur J Pharmacol; 1996 Nov; 315(1):11-8. PubMed ID: 8960859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.